BNP Paribas Financial Markets
PCVX icon

BNP Paribas Financial Markets’s Vaxcyte PCVX Stock Holding History

BNP Paribas Financial Markets’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13M Buy
224,518
+173,756
+342% +$9.43M 0.01% 1422
2025
Q4 		$2.34M Sell
50,762
-206,905
-80% -$9.25M ﹤0.01% 2523
2025
Q3 		$9.28M Buy
257,667
+118,543
+85% +$3.93M 0.01% 1588
2025
Q2 		$4.52M Buy
139,124
+88,692
+176% +$2.91M ﹤0.01% 1921
2025
Q1 		$1.9M Sell
50,432
-40,833
-45% -$3.26M ﹤0.01% 2396
2024
Q4 		$7.47M Buy
+91,265
New +$9.06M 0.01% 1539

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return